{"id":593412,"date":"2019-11-27T04:02:08","date_gmt":"2019-11-27T04:02:08","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/"},"modified":"2019-11-27T04:02:08","modified_gmt":"2019-11-27T04:02:08","slug":"rameda-prices-its-ipo-at-egp-4-66-per-share","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","title":{"rendered":"Rameda prices its IPO at EGP 4.66 per share"},"content":{"rendered":"

<\/a> IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share:<\/strong> Rameda Pharma<\/a> has announced (pdf)<\/a> that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in an initial public offering on the EGX. The Arabic-language public subscription notice (PSN) to local investors is also out today in the domestic press and is here (pdf)<\/a> on Rameda\u2019s website (warning: large download). There\u2019s more background in last month\u2019s intention to float (pdf)<\/a>.<\/p>\n

Greville Investing, the selling shareholder, will offer the bulk of the shares (357,775,700) to institutional investors<\/strong> in an international offering, while the remaining 18,830,300 shares area earmarked for retail investors in Egypt.<\/p>\n

Greville will also subscribe for 125,000,000 newly-issued shares via a closed subscription.<\/strong> This will be funded by a bridge loan, which will later be repaid using some of the proceeds of the retail and international offerings.<\/p>\n

Use of proceeds: <\/strong>Rameda, which bills itself as the fastest growing generic pharma company among the market\u2019s top players, will take in gross proceeds of EGP 582.5 mn on completion of the closed subscription. The company plans to invest the proceeds in expansion, including the acquisition of new molecules and possibly the \u201copportunistic acquisition\u201d of pharma companies.<\/p>\n

enterprise<\/a><\/p>\n

Rameda\u2019s market cap is expected to be around EGP 3.6 bn<\/strong> at the start of trading after the closed subscription, and retail and international offerings.<\/p>\n

Trading is expected to get underway on 11 December under the ticker RMDA,<\/strong> subject to the completion of the closed subscription and approval by the Financial Regulatory Authority and the EGX.<\/p>\n

Advisors:<\/strong> HSBC and Investec are joint global coordinators and bookrunners for the international offering, while CI Capital is joint bookrunner. Compass Capital is the IPO advisor, and Inktank<\/a> is investor relations advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share: Rameda Pharma has announced (pdf) that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in an initial public offering on the EGX. The Arabic-language public subscription notice (PSN) to local investors is also out today in the […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,125,78,449,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-593412","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-investment-watch","tag-ipo-watch","tag-rameda-pharma","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"c239f9f9-9fcd-42fc-8928-e23f59358d77","is_powered_by":true,"story_type":"1","photo_url":"","photo_position":"above","related_issue":[593407],"teaser":"","voice_url":""},"yoast_head":"\nRameda prices its IPO at EGP 4.66 per share - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rameda prices its IPO at EGP 4.66 per share\" \/>\n<meta property=\"og:description\" content=\"IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share: Rameda Pharma has announced (pdf) that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in an initial public offering on the EGX. The Arabic-language public subscription notice (PSN) to local investors is also out today in the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-27T04:02:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ent.news\/2020\/1\/626.jpg\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Rameda prices its IPO at EGP 4.66 per share\",\"datePublished\":\"2019-11-27T04:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\"},\"wordCount\":294,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ent.news\/2020\/1\/626.jpg\",\"keywords\":[\"EnterpriseAM\",\"investment watch\",\"IPO watch\",\"Rameda Pharma\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\",\"name\":\"Rameda prices its IPO at EGP 4.66 per share - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ent.news\/2020\/1\/626.jpg\",\"datePublished\":\"2019-11-27T04:02:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage\",\"url\":\"https:\/\/ent.news\/2020\/1\/626.jpg\",\"contentUrl\":\"https:\/\/ent.news\/2020\/1\/626.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rameda prices its IPO at EGP 4.66 per share\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rameda prices its IPO at EGP 4.66 per share - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","og_locale":"en_US","og_type":"article","og_title":"Rameda prices its IPO at EGP 4.66 per share","og_description":"IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share: Rameda Pharma has announced (pdf) that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in an initial public offering on the EGX. The Arabic-language public subscription notice (PSN) to local investors is also out today in the […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2019-11-27T04:02:08+00:00","og_image":[{"url":"https:\/\/ent.news\/2020\/1\/626.jpg","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Rameda prices its IPO at EGP 4.66 per share","datePublished":"2019-11-27T04:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/"},"wordCount":294,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage"},"thumbnailUrl":"https:\/\/ent.news\/2020\/1\/626.jpg","keywords":["EnterpriseAM","investment watch","IPO watch","Rameda Pharma","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","name":"Rameda prices its IPO at EGP 4.66 per share - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage"},"thumbnailUrl":"https:\/\/ent.news\/2020\/1\/626.jpg","datePublished":"2019-11-27T04:02:08+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#primaryimage","url":"https:\/\/ent.news\/2020\/1\/626.jpg","contentUrl":"https:\/\/ent.news\/2020\/1\/626.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Rameda prices its IPO at EGP 4.66 per share"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":593462,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","url_meta":{"origin":593412,"position":0},"title":"FRA gives Rameda green light on public subscription notice","author":"enterpriseam admin","date":"28 November 2019","format":false,"excerpt":"IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda Pharma\u2019s public subscription notice (pdf) to local investors for its initial public offering on the EGX, according to a statement to the bourse (pdf). Rameda has announced (pdf) that it\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":591230,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/01\/rameda-pharma-retail-offering-oversubscribed-on-first-day\/","url_meta":{"origin":593412,"position":1},"title":"Rameda Pharma retail offering oversubscribed on first day","author":"enterpriseam admin","date":"1 December 2019","format":false,"excerpt":"IPO WATCH- Rameda Pharma retail offering oversubscribed on first day: The retail component of Rameda\u2019s IPO was oversubscribed at the close of play on Thursday, market sources told the local press. Retail investors put in orders for 19.65 mn shares, handily covering the 18.83 mn shares offered by the pharma\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":591422,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/05\/rameda-pharma-retail-subscription-surges-on-final-day-offering-closes-33x-oversubscribed\/","url_meta":{"origin":593412,"position":2},"title":"Rameda Pharma retail subscription surges on final day, offering closes 33x oversubscribed","author":"enterpriseam admin","date":"5 December 2019","format":false,"excerpt":"Retail appetite for Rameda\u2019s IPO surgest on last day; offering closing 36.3x oversubscribed: Retail investors poured into Rameda Pharma\u2019s 5% public offering on the final day of subscription yesterday, leading the retail component to close 36.3x oversubscribed, Al Mal reports. Investors had placed orders for 683.22 mn shares by the\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":591282,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/02\/rameda-retail-offering-1-6x-oversubscribed-on-second-day-of-subscription\/","url_meta":{"origin":593412,"position":3},"title":"Rameda retail offering 1.6x oversubscribed on second day of subscription","author":"enterpriseam admin","date":"2 December 2019","format":false,"excerpt":"IPO WATCH- Rameda retail offering 1.6x oversubscribed on second day of subscription: Rameda Pharma\u2019s retail offering was 1.6x oversubscribed at the end of the second day of subscription yesterday, according to the local press. Retail investors bid for 29.96 mn shares from a total 18.83 mn shares on offer. The\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":594494,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","url_meta":{"origin":593412,"position":4},"title":"Rameda announces intention to IPO in 4Q2019","author":"enterpriseam admin","date":"31 October 2019","format":false,"excerpt":"IPO WATCH- Rameda announces intention to IPO in 4Q2019: Rameda Pharma, the country\u2019s fastest-growing generic pharmaceuticals player, announced yesterday morning its intention to sell an undisclosed number of shares in an initial public offering on the EGX in 4Q2019. The company is planning an offering to institutional and international investors\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":593231,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/21\/rameda-receives-greenlight-for-ipo-this-year\/","url_meta":{"origin":593412,"position":5},"title":"Rameda receives greenlight for IPO this year","author":"enterpriseam admin","date":"21 November 2019","format":false,"excerpt":"IPO WATCH- Rameda gets nod for share listing, will go public before the end of the year \u2013FRA: Rameda Pharma has received approval from the Financial Regulatory Authority (FRA) to go public on the EGX before the end of this year, FRA boss Mohamed Omran said at a press conference\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2019\/8\/EGX-1600px.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/593412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=593412"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/593412\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/593407"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=593412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=593412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=593412"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=593412"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=593412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}